Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research, and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day:
Study of genomic landscape of IgM-MGUS and patients with stable or progressive asymptomatic Waldenström macroglobulinemia finds CD79B, ARID1A, and CREBBP more often mutated in progressers; MYD88L265 VAF also significantly higher.”
Title: Genomic landscape of IgM-MGUS and patients with stable or progressive asymptomatic Waldenström macroglobulinemia
Authors: Tina Bagratuni, Ourania Theologi, Christos Vlachos, Ioannis Kollias, Kylee H. Maclachlan, Foteini Aktypi, Nefeli Mavrianou-Koutsoukou, Christine I Liacos, Konstantina Taouxi, Alexandra Papadimou, Katerina Chrisostomidou, Maria Sakkou, Irene Solia, Foteini Theodorakou, Gianmarco Favrin, Maria Gavriatopoulou, Evangelos Terpos, Marzia Varettoni, Zachary R Hunter, Steven P. Treon, Francesco Maura, Meletios-Athanasios Athanasios Dimopoulos, Efstathios Kastritis
You can read the Full Article in Blood.
You can find more posts featuring Robert Orlowski on OncoDaily.
